Cellspin Soft Challenges Denials for Director Review at the CAFC – On Wednesday, December 1, patent owner Cellspin Soft filed a supplemental brief at the Federal Circuit asking the appellate court to vacate and remand denials for Director review of final written decisions in IPR proceedings conducted at the PTAB. Cellspin is challenging the validity of the order under the Supreme Court’s ruling in United States v. Arthrex, and for violations of the Administrative Procedures Act for failing both to provide sufficient reasoning for the order’s decision and for lack of notice and comment rulemaking in developing the Director review process.
Originally published in IPWatchdog. Cellspin Soft, Inc. is represented by Garteiser Honea.
